Abstract
The value of measuring levels of glycated hemoglobin (HbA1c) for the prediction of first cardiovascular events is uncertain.To determine whether adding information on HbA1c values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk.Analysis of individual-participant data available from 73 prospective studies involving 294,998 participants without a known history of diabetes mellitus or CVD at the baseline assessment.Measures of risk discrimination for CVD outcomes (eg, C-index) and reclassification (eg, net reclassification improvement) of participants across predicted 10-year risk categories of low (
| Original language | English |
|---|---|
| Pages (from-to) | 1225-1233 |
| Number of pages | 9 |
| Journal | JAMA-Journal of the American Medical Association |
| Volume | 311 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 26 Mar 2014 |
Fingerprint
Dive into the research topics of 'Glycated Hemoglobin Measurement and Prediction of Cardiovascular Disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver